Delta-Fly Pharma, Inc. (4598.T)

JPY 714.0

(3.18%)

Total Liabilities Summary of Delta-Fly Pharma, Inc.

  • Delta-Fly Pharma, Inc.'s latest annual total liabilities in 2023 was 241.49 Million JPY , up 108.87% from previous year.
  • Delta-Fly Pharma, Inc.'s latest quarterly total liabilities in 2024 Q1 was 96 Million JPY , down -43.88% from previous quarter.
  • Delta-Fly Pharma, Inc. reported annual total liabilities of 115.61 Million JPY in 2022, up 26.79% from previous year.
  • Delta-Fly Pharma, Inc. reported annual total liabilities of 91.19 Million JPY in 2021, up 10.58% from previous year.
  • Delta-Fly Pharma, Inc. reported quarterly total liabilities of 241.49 Million JPY for 2023 Q4, up 165.38% from previous quarter.
  • Delta-Fly Pharma, Inc. reported quarterly total liabilities of 91 Million JPY for 2023 Q3, up 3.48% from previous quarter.

Annual Total Liabilities Chart of Delta-Fly Pharma, Inc. (2023 - 2019)

Historical Annual Total Liabilities of Delta-Fly Pharma, Inc. (2023 - 2019)

Year Total Liabilities Total Liabilities Growth
2023 241.49 Million JPY 108.87%
2022 115.61 Million JPY 26.79%
2021 91.19 Million JPY 10.58%
2020 82.46 Million JPY 1346.74%
2019 5.7 Million JPY 0.0%

Peer Total Liabilities Comparison of Delta-Fly Pharma, Inc.

Name Total Liabilities Total Liabilities Difference
KOHJIN BIO CO LTD 3.24 Billion JPY 92.562%
PRISM BioLab Co.,LTD 63.41 Million JPY -280.844%
GNI Group Ltd. 26.34 Billion JPY 99.083%
Linical Co., Ltd. 10.3 Billion JPY 97.656%
Trans Genic Inc. 3.81 Billion JPY 93.666%
MEDINET Co., Ltd. 590.2 Million JPY 59.082%
Soiken Holdings Inc. 697.02 Million JPY 65.353%
Cytori Cell Research Institute, Inc. 3.02 Billion JPY 92.005%
AnGes, Inc. 2.78 Billion JPY 91.342%
OncoTherapy Science, Inc. 513.6 Million JPY 52.98%
Nxera Pharma Co., Ltd. 90.38 Billion JPY 99.733%
Immuno-Biological Laboratories Co., Ltd. 353.27 Million JPY 31.64%
NanoCarrier Co., Ltd. 1.64 Billion JPY 85.363%
Carna Biosciences, Inc. 472.35 Million JPY 48.874%
CanBas Co., Ltd. 91.98 Million JPY -162.531%
D. Western Therapeutics Institute, Inc. 1.09 Billion JPY 77.917%
RaQualia Pharma Inc. 809.83 Million JPY 70.179%
Chiome Bioscience Inc. 593.73 Million JPY 59.326%
Kidswell Bio Corporation 4.25 Billion JPY 94.323%
PeptiDream Inc. 29.11 Billion JPY 99.171%
Oncolys BioPharma Inc. 566.5 Million JPY 57.37%
Ribomic Inc. 155.8 Million JPY -54.996%
SanBio Company Limited 2.25 Billion JPY 89.29%
Healios K.K. 11.28 Billion JPY 97.86%
BrightPath Biotherapeutics Co., Ltd. 251.26 Million JPY 3.889%
Kubota Pharmaceutical Holdings Co., Ltd. 369 Million JPY 34.554%
StemRIM 187 Million JPY -29.143%
CellSource Co., Ltd. 677.73 Million JPY 64.367%
FunPep Company Limited 189.32 Million JPY -27.558%
Kringle Pharma, Inc. 596.95 Million JPY 59.545%
Stella Pharma Corporation 1.44 Billion JPY 83.271%
TMS Co., Ltd. 97.68 Million JPY -147.21%
Noile-Immune Biotech Inc. 91.49 Million JPY -163.948%
Cuorips Inc. 200.96 Million JPY -20.171%
K Pharma,Inc. 209.13 Million JPY -15.475%
Takara Bio Inc. 11.42 Billion JPY 97.885%
ReproCELL Incorporated 741.03 Million JPY 67.411%
PhoenixBio Co., Ltd. 917.71 Million JPY 73.685%
StemCell Institute Inc. 3.85 Billion JPY 93.728%
Japan Tissue Engineering Co., Ltd. 908.43 Million JPY 73.416%
CellSeed Inc. 301.04 Million JPY 19.781%